vcvibes

Longitude Capital Management Co., LLC

Longitude Venture Partners V, L.P.

Late investment period

Late investment period: first sale Aug 2022, per Form D (fund age approximates vintage)

Open their pitch form
Vintage
2022
Fund size
$206.68M to $600M (Form D)
Stages
Growth
Sectors
Biotech, Medical devices, Healthtech
Regions
Not stated

01 · Thesis

Longitude Capital makes venture growth investments in biotechnology, medical technology, and health solutions companies that improve clinical outcomes, enhance patient quality of life, and reduce the cost of care. It builds balanced portfolios of clinical-stage and commercial-stage companies using venture capital, royalties, PIPEs, and equity-linked instruments.Inferred from the firm's website

02 · Initial check

$6.89M to $37.5M (estimated from fund size)

Estimated from Form D: $206.68M sold of a $600M target

03 · Who to approach

Named on this fund's Form D

  • Juliet Tammenoms Bakker, Managing Member of the General Partner
  • Patrick Enright, Managing Member of the General Partner

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideLongitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care.

    Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care.
    https://www.longitudecapital.com/

06 · Sources

  1. https://www.longitudecapital.com/
  2. https://www.sec.gov/Archives/edgar/data/1935964/000193596423000001/

Last verified: Oct 28, 2026